TE
Trails Edge Capital Partners, LP disclosed a 5.4% stake in FTH
Trails Edge Capital Partners, LP reported owning 5.4% of Faeth Therapeutics, Inc. (FTH) (1,385,878 shares) in a Schedule 13G filed Nov 17, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 17, 2026
- Source
- Schedule 13G